# BMPR1B

## Overview
The BMPR1B gene encodes the bone morphogenetic protein receptor type 1B, a receptor serine/threonine kinase that plays a pivotal role in the bone morphogenetic protein (BMP) signaling pathway. This receptor is integral to various biological processes, including skeletal development, chondrogenesis, and ovarian folliculogenesis. The protein is characterized by its extracellular ligand-binding domain, a transmembrane domain, and an intracellular kinase domain, which facilitate its function in signal transduction. Mutations in BMPR1B have been linked to several skeletal disorders, such as brachydactyly and acromesomelic chondrodysplasia, highlighting its clinical significance in bone and cartilage development (Racacho2015Two; GraulNeumann2013Homozygous). Additionally, BMPR1B's involvement in the regulation of reproductive processes underscores its broader physiological importance (Regan2016Dysregulation).

## Structure
The BMPR1B gene encodes a protein that is a receptor serine/threonine kinase involved in the bone morphogenetic protein (BMP) signaling pathway. The protein is composed of 502 amino acids and includes several key domains: an extracellular ligand-binding domain (LBD), a single transmembrane domain, a glycine-serine-rich box (GS), and an intracellular kinase domain (KD) (Lehmann2003Mutations; GraulNeumann2013Homozygous). The LBD is crucial for binding ligands such as GDF5, and mutations in this domain can affect the protein's structure and function (Stange2015A; GraulNeumann2013Homozygous).

The protein's secondary structure includes alpha helices and beta sheets, which contribute to its 3D folding, or tertiary structure. The quaternary structure may involve dimerization, which is common in receptor kinases. Post-translational modifications, such as phosphorylation, are important for the protein's function, particularly in the GS domain, which is involved in phosphorylation and kinase activity (Lehmann2003Mutations).

Mutations in BMPR1B can lead to various skeletal disorders, such as brachydactyly type A1 and A2, by disrupting normal signaling pathways and protein function (Racacho2015Two; Lehmann2003Mutations).

## Function
BMPR1B (bone morphogenetic protein receptor type 1B) is a serine/threonine kinase receptor that plays a crucial role in the bone morphogenetic protein (BMP) signaling pathway, which is part of the TGF-β superfamily. This receptor is involved in various cellular processes, including proliferation, differentiation, and apoptosis, which are essential for skeletal formation and repair (Wang2014Bone).

In the context of ovarian function, BMPR1B is integral to folliculogenesis, the maturation process of ovarian follicles. It forms a complex with BMP ligands and the type 2 TGFβ receptor BMPR2, initiating a signaling cascade that involves the phosphorylation of receptor-regulated Smads. These Smads then form a complex with Smad 4, translocate to the nucleus, and influence the transcription of BMP-responsive genes. This signaling is essential for the proper development and selection of dominant follicles, which are crucial for ovulation (Regan2016Dysregulation).

BMPR1B is also involved in chondrogenesis, where it is necessary for transducing BMP signals from the extracellular matrix to the nucleus. The receptor's activity is crucial for maintaining normal skeletal development, as it influences chondrocyte proliferation and differentiation in growth plates, which are critical for the growth of long bones in the limbs (Long2021A).

## Clinical Significance
Mutations in the BMPR1B gene are associated with several skeletal disorders. Brachydactyly type A1 (BDA1) is linked to novel pathogenic variants in BMPR1B, such as the c.975A>C (p.Lys325Asn) mutation, which leads to hypoplasia or aplasia of the middle phalanges of digits 2-5. This mutation acts in a dominant-negative manner, significantly impairing BMPR1B function and reducing chondrogenic activity (Racacho2015Two). 

Acromesomelic chondrodysplasia-type Grebe is caused by homozygous missense and nonsense mutations in BMPR1B, such as c.157T>C (p.C53R) and c.657G>A (p.W219*). These mutations result in severe limb shortening and other skeletal abnormalities due to a loss of function in the BMPR1B gene (GraulNeumann2013Homozygous).

Du Pan acromesomelic dysplasia is associated with the hypomorphic p.Arg31Cys mutation in BMPR1B, leading to mild limb shortening and skeletal anomalies. This mutation results in reduced signal transduction capacity, affecting bone development (Stange2015A).

BMPR1B mutations are also implicated in idiopathic pulmonary arterial hypertension (IPAH), with specific missense mutations like c.479G>A (p.S160N) and c.1176C>A (p.F392L) identified in patients. These mutations may alter BMP signaling, contributing to the pathogenesis of IPAH (Chida2012Missense).

## Interactions
BMPR1B, a receptor in the bone morphogenetic protein (BMP) signaling pathway, interacts with several proteins that are crucial for its function. It forms complexes with BMP ligands such as BMP2 and BMP4, which are essential for signal transduction processes that regulate cellular activities like bone and cartilage development (Jia2020Eukaryotic). BMPR1B also interacts with growth differentiation factors like GDF5 and GDF9, which play roles in ovarian folliculogenesis and ovulation in ewes (Jia2020Eukaryotic).

The receptor is involved in a protein-protein interaction network that includes Smad proteins, which are key mediators of the TGF-beta signaling pathway. These interactions are significant for the regulation of reproductive processes and signal transduction between intracellular and extracellular environments (Jia2020Eukaryotic).

BMPR1B is also subject to inhibitory interactions. The SMOC2 protein, both in its wild-type and mutant forms, inhibits BMP signaling by competitively binding to BMPR1B. This competitive binding affects the receptor's ability to interact with BMP2, thereby modulating the BMP-SMAD1/5/9 signaling pathway, which is crucial for chondrogenesis and skeletal development (Long2021A).


## References


[1. (Racacho2015Two) Lemuel Racacho, Ashley M Byrnes, Heather MacDonald, Helen J Dranse, Sarah M Nikkel, Judith Allanson, Elisabeth Rosser, T Michael Underhill, and Dennis E Bulman. Two novel disease-causing variants in bmpr1b are associated with brachydactyly type a1. European Journal of Human Genetics, 23(12):1640–1645, March 2015. URL: http://dx.doi.org/10.1038/ejhg.2015.38, doi:10.1038/ejhg.2015.38. This article has 16 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/ejhg.2015.38)

[2. (Stange2015A) Katja Stange, Julie Désir, Naseebullah Kakar, Thomas D. Mueller, Birgit S. Budde, Christopher T. Gordon, Denise Horn, Petra Seemann, and Guntram Borck. A hypomorphic bmpr1b mutation causes du pan acromesomelic dysplasia. Orphanet Journal of Rare Diseases, June 2015. URL: http://dx.doi.org/10.1186/s13023-015-0299-5, doi:10.1186/s13023-015-0299-5. This article has 17 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s13023-015-0299-5)

[3. (Lehmann2003Mutations) Katarina Lehmann, Petra Seemann, Sigmar Stricker, Marai Sammar, Birgit Meyer, Katrin Süring, Frank Majewski, Sigrid Tinschert, Karl-Heinz Grzeschik, Dietmar Müller, Petra Knaus, Peter Nürnberg, and Stefan Mundlos. Mutations in bone morphogenetic protein receptor 1b cause brachydactyly type a2. Proceedings of the National Academy of Sciences, 100(21):12277–12282, October 2003. URL: http://dx.doi.org/10.1073/pnas.2133476100, doi:10.1073/pnas.2133476100. This article has 137 citations.](https://doi.org/10.1073/pnas.2133476100)

[4. (Jia2020Eukaryotic) Jianlei Jia, Jipeng Jin, Qian Chen, Zan Yuan, Haiqin Li, Junhao Bian, and Linsheng Gui. Eukaryotic expression, co-ip and ms identify bmpr-1b protein–protein interaction network. Biological Research, May 2020. URL: http://dx.doi.org/10.1186/s40659-020-00290-7, doi:10.1186/s40659-020-00290-7. This article has 26 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s40659-020-00290-7)

[5. (GraulNeumann2013Homozygous) Luitgard M Graul-Neumann, Alexandra Deichsel, Ulrike Wille, Naseebullah Kakar, Randi Koll, Christian Bassir, Jamil Ahmad, Valerie Cormier-Daire, Stefan Mundlos, Christian Kubisch, Guntram Borck, Eva Klopocki, Thomas D Mueller, Sandra C Doelken, and Petra Seemann. Homozygous missense and nonsense mutations in bmpr1b cause acromesomelic chondrodysplasia-type grebe. European Journal of Human Genetics, 22(6):726–733, October 2013. URL: http://dx.doi.org/10.1038/ejhg.2013.222, doi:10.1038/ejhg.2013.222. This article has 21 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/ejhg.2013.222)

[6. (Chida2012Missense) Ayako Chida, Masaki Shintani, Tomotaka Nakayama, Yoshiyuki Furutani, Emiko Hayama, Kei Inai, Tsutomu Saji, Shigeaki Nonoyama, and Toshio Nakanishi. Missense mutations of the &lt;i&gt;bmpr1b&lt;/i&gt; (&lt;i&gt;alk6&lt;/i&gt;) gene in childhood idiopathic pulmonary arterial hypertension. Circulation Journal, 76(6):1501–1508, 2012. URL: http://dx.doi.org/10.1253/CIRCJ.CJ-11-1281, doi:10.1253/circj.cj-11-1281. This article has 113 citations and is from a peer-reviewed journal.](https://doi.org/10.1253/CIRCJ.CJ-11-1281)

[7. (Regan2016Dysregulation) Sheena L.P. Regan, Phil G. Knight, John L. Yovich, James D. Stanger, Yee Leung, Frank Arfuso, Arun Dharmarajan, and Ghanim Almahbobi. Dysregulation of granulosal bone morphogenetic protein receptor 1b density is associated with reduced ovarian reserve and the age-related decline in human fertility. Molecular and Cellular Endocrinology, 425:84–93, April 2016. URL: http://dx.doi.org/10.1016/j.mce.2016.01.016, doi:10.1016/j.mce.2016.01.016. This article has 21 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.mce.2016.01.016)

[8. (Wang2014Bone) Richard N. Wang, Jordan Green, Zhongliang Wang, Youlin Deng, Min Qiao, Michael Peabody, Qian Zhang, Jixing Ye, Zhengjian Yan, Sahitya Denduluri, Olumuyiwa Idowu, Melissa Li, Christine Shen, Alan Hu, Rex C. Haydon, Richard Kang, James Mok, Michael J. Lee, Hue L. Luu, and Lewis L. Shi. Bone morphogenetic protein (bmp) signaling in development and human diseases. Genes &amp; Diseases, 1(1):87–105, September 2014. URL: http://dx.doi.org/10.1016/j.gendis.2014.07.005, doi:10.1016/j.gendis.2014.07.005. This article has 761 citations.](https://doi.org/10.1016/j.gendis.2014.07.005)

[9. (Long2021A) Feng Long, Hongbiao Shi, Pengyu Li, Shaoqiang Guo, Yuer Ma, Shijun Wei, Yan Li, Fei Gao, Shang Gao, Meitian Wang, Ruonan Duan, Xiaojing Wang, Kun Yang, Wenjie Sun, Xi Li, Jiangxia Li, and Qiji Liu. A smoc2 variant inhibits bmp signaling by competitively binding to bmpr1b and causes growth plate defects. Bone, 142:115686, January 2021. URL: http://dx.doi.org/10.1016/j.bone.2020.115686, doi:10.1016/j.bone.2020.115686. This article has 18 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.bone.2020.115686)